Robin Kral

Corporate Officer/Principal presso REATA PHARMACEUTICALS, INC.

Consumer Services

Health Technology

Profilo

Robin Kral currently works at Reata Pharmaceuticals, Inc., as Vice President-Licensing & Intellectual Property from 2004.
Mr. Kral also formerly worked at The University of Texas Southwestern Medical Center, as Associate Director-Venture Development and NPS Pharmaceuticals, Inc., as Principal.
Mr. Kral received his undergraduate degree and graduate degree from Texas Tech University and Masters Business Admin degree from David Eccles School of Business.

Posizioni attive di Robin Kral

Società	Posizione	Inizio
REATA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2004

Tutte le posizioni attive di Robin Kral

Precedenti posizioni note di Robin Kral

Società	Posizione	Fine
The University of Texas Southwestern Medical Center	Corporate Officer/Principal	-
NPS PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Robin Kral

Formazione di Robin Kral

Texas Tech University	Graduate Degree
David Eccles School of Business	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Robin Kral

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Reata Pharmaceuticals, Inc. Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX.	Health Technology
NPS Pharmaceuticals, Inc. NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ.	Health Technology